Avantor, Inc. $AVTR Position Cut by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 5.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,027,738 shares of the company's stock after selling 118,991 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.30% of Avantor worth $20,075,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Avantor during the second quarter valued at approximately $695,784,000. Wellington Management Group LLP bought a new stake in shares of Avantor in the 4th quarter worth $268,584,000. Engine Capital Management LP lifted its holdings in shares of Avantor by 65.8% in the first quarter. Engine Capital Management LP now owns 19,780,830 shares of the company's stock valued at $155,082,000 after buying an additional 7,853,018 shares during the period. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of Avantor in the second quarter valued at $195,386,000. Finally, Morgan Stanley boosted its stake in Avantor by 179.4% during the fourth quarter. Morgan Stanley now owns 17,468,418 shares of the company's stock valued at $200,188,000 after buying an additional 11,216,565 shares in the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently commented on AVTR shares. Barclays boosted their target price on shares of Avantor from $7.00 to $8.00 and gave the stock an "underweight" rating in a report on Wednesday, June 24th. TD Cowen restated a "hold" rating on shares of Avantor in a research report on Wednesday, July 15th. Wall Street Zen raised Avantor from a "hold" rating to a "buy" rating in a report on Saturday, June 27th. Royal Bank Of Canada increased their price objective on Avantor from $9.00 to $14.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Finally, Wolfe Research raised Avantor from a "strong sell" rating to a "hold" rating in a research note on Thursday, July 30th. Two investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $12.00.

Avantor Price Performance

NYSE AVTR opened at $14.96 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $10.12 billion, a PE ratio of -17.81, a price-to-earnings-growth ratio of 11.46 and a beta of 0.89. Avantor, Inc. has a 12-month low of $7.26 and a 12-month high of $15.93. The company has a 50 day moving average price of $12.62 and a two-hundred day moving average price of $9.93.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.02. The company had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.61 billion. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The business's quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.24 earnings per share. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. As a group, equities analysts predict that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc NYSE: AVTR is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor's offerings are organized across two primary segments.

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source